Heyholder
‹ Activism Filings

Yuyu Pharma, Inc. Yu Won-sang group holds 35.95% unchanged, share-backed loan extended

Yuyu Pharma, Inc.· Report on Large Shareholdings

AI summary · Not investment advice

Yu Won-sang and 12 related parties' holdings in Yuyu Pharma, Inc. rose by 1,000 shares, with the stake unchanged at 35.95%; pledged shares total 1,549,800.

Stake

35.95%

Previous 35.95%; 0%p

Key facts

Reporting holder
Yu Won-sang and 12 related parties
Previous stake
35.95%
Purpose of holding
Influence on management control
Relationship with issuer
Largest shareholder
Report type
Change and amendment
Reason for report
Extension of a share-backed loan; on-market purchase of related-party shares
Previous shares held
5,660,598 shares
Shares held
5,661,598 sharesChange of +1,000 shares
Method of change
On-market purchase of related-party shares
Reason for amendment
Extension of share-backed loan
Previous shares under major contracts
1,549,800 sharesRatio 9.84%
Shares under major contracts
1,549,800 sharesRatio 9.84%
Total under contracts
1,549,800 sharesTotal ratio 9.84%
Source of funds
KRW 3.7 millionOwn funds of a related party; no borrowings
Reporting obligation date
Nov 9, 2026

Commentary

AI commentary · Not investment advice

What happened

Yuyu Pharma, Inc.'s largest shareholder Yu Won-sang and 12 related parties reported a 1,000-share increase in their holdings. The increase belongs to one related party. The filing lists the method as an on-market purchase of related-party shares, and the detail table says it was corrected after checking the shareholder register. The acquisition funds were KRW 3.7 million. Their holdings moved from 5,660,598 shares to 5,661,598 shares. Their ownership ratio stayed at 35.95%. The stated purpose is to influence management control.

In the company's terms

The reason for the amendment is an extension of a stock-backed loan (a loan secured by pledged shares). The pledge contracts cover 670,000 shares and 579,499 shares for Yu Won-sang, and 300,301 shares for a related party. The pledge contracts total 1,549,800 shares.

Comments

No comments yet

Comments from shareholders will appear here.